TRI-CON 2023 Poster Presentations Coming in February
2022 Poster Presentations:
P01: Unbiased Proteomic Profiling Leads to the Discovery of a Novel Non-Invasive Blood-Based Protein Panel, Presented by Ben G., Biognosys, Inc.
P02: Empathetic Systems Engineering - Optimizing from Chemistry Through Sensing and AI-Driven Insight and Back Again, Presented by Andrew G., Cambridge Consultants Ltd.
P03: Non-Invasive Melanoma Detection Through Gene-Expression Analysis on Skin Tissue Collected via Adhesive Patches, Presented by Kulvinder K., DermTech, Inc.
P04: CoVariant-SCAN: A Rapid Test to Assess the Immune Escape of SARS-CoV-2 Variants, Presented by Jacob H., Duke University
P05: Analyzing Factors Affecting an Acquisition of Neutralizing Antibody Against COVID-19 Using the RapiSure™ (EDGCTM) COVID-19 S1 RBD IgG/Neutralizing Ab Test, Presented by Kyongchol K., Eone Diagnomics Genome Center (EDGC)
P06: Advanced Understanding of the Tumor Microenvironment with Multiplex Immunofluorescence: An Automated 7-Color Multiplex Assay Using Akoya's MOTiF PD-1/PD-L1 Panel Kit for Immuno-Oncology, Presented by Bhavika P., Lanterne Dx
P07: CosMx Spatial Molecular Imager: New Platform for Spatially Resolved RNA and Protein Expression at Single Cell and Subcellular Resolution, Presented by Sarah W., NanoString Technologies, Inc.
P08: Colorimetric RT-LAMP for Rapid, Simple Molecular Diagnostics, Presented by Nathan T., New England Biolabs
P09: Eliminating Biochemical and Immunological Negative Regulators to Improve Cancer Immunotherapies, Presented by Stephen H., Northeastern University
P10: Large-Scale Systematic Feasibility Study on the Pan-Cancer Predictability of Multi-Omic Biomarkers from Whole Slide Images with Deep Learning, Presented by Martin B., Panakeia Technologies Ltd.
P11: Improvements in the Quantitative Power of Digital PCR for Microbial DNA Detection in Complex Human Samples, Presented by April A., University of California, San Diego
P12: Development of a Rapid Cross-Kingdom Molecular Assay for Broad-Based Screening and Quantification of Bacterial, Viral, and Fungal Pathogens, Presented by Tyler G., University of California, San Diego
P13: POC Molecular Testing Platform for COVID Testing and Beyond, Presented by Ming T., Wainamics, Inc.
P14: The SalivaDirect Initiative COVID-19 Response National Laboratory Network, Presented by Brittany C., Yale School of Public Health/SalivaDirect
P15: Saliva as a Reliable Sample Type for Mass SARS-CoV-2 Testing Strategies, Presented by Anne W., Yale School of Public Health/SalivaDirect
P16: Kinetics of Plasma cfDNA Predicts Clinical Response in Non-Small Cell Lung Cancer Patients, Presented by Michael S., DiaCarta, Inc.
P17: Target Enrichment for BRAF V600 Mutant Detection by Sanger Sequencing, Presented by Michael S., DiaCarta, Inc.
P18: Novel In Vitro Diagnostic Medical Device for Personalized Medicine in Rheumatoid Arthritis-Predicting of Infliximab Treatment Responsiveness to Support Early Therapy Selection, Presented by Laszlo S., EGIS Pharmaceuticals PLC